TCL Archive ACS Journal Cancer Refers I-ELCAP Studies to Office of Human Research Protections January 6, 2012
TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. April 21, 2006
TCL Archive Who Will Determine Pay Lines For Each Program at NCI? Upton Suggests A Collective Approach February 17, 1978
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006